Chicago-based Durata Therapeutics, Inc. (NASDAQ:DRTX) has announced that the US FDA has approved the sale and distribution of its new antibiotic for the treatment of common bacterial skin infections which are acquired in the hospitals. Durata Therapeutics Inc. (NASDAQ:DRTX) weekly performance is 6.03%. On last trading day company shares ended up $16.89. Analysts mean target price for the company is $19.72. Durata Therapeutics Inc. (NASDAQ:DRTX) distance from 50-day simple moving average (SMA50) is 19.52%.
Anthony Nolan and Pacific Biosciences of California (NASDAQ:PACB) have announced that Anthony Nolan is the world’s first stem cell registry to invest in an innovative new technology for advanced tissue typing. The charity has purchased two PacBio RS II systems, which enable Single Molecule, Real-Time DNA Sequencing of full-length HLA genes. Pacific Biosciences of California (NASDAQ:PACB) shares advanced 5.39% in last trading session and ended the day on $4.69. PACB gross Margin is 22.70% and its return on assets is -56.30%.Pacific Biosciences of California (NASDAQ:PACB) quarterly performance is -34.41%.
On May 22, 2014, Omeros Corporation (NASDAQ:OMER) and Ventiv Commercial Services, LLC, an inVentiv Health company (“Ventiv”), entered into a Project Agreement pursuant to which Ventiv will provide to Omeros a field force of 20 Ventiv sales representatives, a part time national business director and a part time operations manager, to provide detailing services and sales operation services related to Omidria, if approved. Omeros Corporation (NASDAQ:OMER) shares moved up 12.00% in last trading session and was closed at $11.67, while trading in range of $10.17 – $11.76. Omeros Corporation (NASDAQ:OMER) year to date (YTD) performance is 3.37%.
Northwest Biotherapeutics (NASDAQ:NWBO) posted its quarterly earnings results on 21 may. The company reported ($0.46) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.33) by $0.13, Analyst Ratings Network.com reports. Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) ended the last trading day at $5.83. Company weekly volatility is calculated as 4.40% and price to cash ratio as 18.03.
Transcept Pharmaceuticals (NASDAQ:TSPT) announced a special dividend on Wednesday, May 14th, AmericanBankingNews.com reports. Investors of record on Monday, May 26th will be paid a dividend of 1.33 per share on Tuesday, June 3rd. Transcept Pharmaceuticals Inc. (NASDAQ:TSPT) weekly performance is 4.21%. On last trading day company shares ended up $3.22. Analysts mean target price for the company is $4.10. Transcept Pharmaceuticals Inc. (NASDAQ:TSPT) distance from 50-day simple moving average (SMA50) is 6.88%.
Leave a Reply